Advanced search
Publication Cover
Current Medical Research and Opinion Volume 34, 2018 - Issue 5: Oncology
Submit an article Journal homepage
420
Views
21
CrossRef citations to date
0
Altmetric
Oncology

Tyrosine kinase inhibitors for advanced or metastatic thyroid cancer: a meta-analysis of randomized controlled trials

Jen-Wei LiuDepartment of Pharmacy, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan; ;School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan;
,
Chiehfeng ChenCochrane Taiwan, Taipei Medical University, Taipei, Taiwan; ;Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; ;Division of Plastic Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan;
,
El-Wui LohCenter for Evidence-Based Health Care, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan;
,
Chun-Cheng ChuSchool of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan;
,
Mu-Yi WangSchool of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan;
,
Hsin-Ju OuyangSchool of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan;
,
Ya-Ting ChangSchool of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan;
,
Wei-Zhan ZhuangSchool of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan;
,
Ching-Wen ChouSchool of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan;
,
Der-Jr HuangSchool of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan;
,
Chia-Hwa LeeSchool of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan; ;Comprehensive Cancer Center of Taipei Medical University, Taipei, Taiwan; ;Department of Laboratory Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan;
,
Yun YenGraduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan;
&
Ka-Wai TamCochrane Taiwan, Taipei Medical University, Taipei, Taiwan; ;Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, TaiwanCorrespondence[email protected]
 show all
Pages 795-803 | Received 02 May 2017, Accepted 14 Aug 2017, Published online: 12 Sep 2017

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

El-Wui Loh & Ka-Wai Tam. (2022) Reply to letter to editor concerning “tyrosine kinase inhibitors for advanced or metastatic thyroid cancer: a meta-analysis of randomized controlled trials”. Current Medical Research and Opinion 38:10, pages 1771-1771.
Read now
Jingyang Su, Yue Fu, Menglei Wang, Jiang Yan & Shengyou Lin. (2022) The pathogenesis and treatment differences between differentiated thyroid carcinoma and medullary thyroid carcinoma. Current Medical Research and Opinion 38:10, pages 1769-1770.
Read now
Maria V Deligiorgi, Mihalis I Panayiotidis & Dimitrios T Trafalis. (2020) Prophylactic Lymph Node Dissection in Clinically N0 Differentiated Thyroid Carcinoma: Example of Personalized Treatment. Personalized Medicine 17:4, pages 317-338.
Read now
Shi-Tong Yu, Jun-Na Ge, Jing-Yi Luo, Zhi-Gang Wei, Bai-Hui Sun & Shang-Tong Lei. (2019) Treatment-related adverse effects with TKIs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis. Cancer Management and Research 11, pages 1525-1532.
Read now
Silvia Martina Ferrari, Poupak Fallahi, Concettina La Motta, Giusy Elia, Francesca Ragusa, Ilaria Ruffilli, Armando Patrizio, Enke Baldini, Salvatore Ulisse & Alessandro Antonelli. (2019) Recent advances in precision medicine for the treatment of anaplastic thyroid cancer. Expert Review of Precision Medicine and Drug Development 4:1, pages 37-49.
Read now

Articles from other publishers (16)

Mingjian ZhaoRuowen LiZhimin SongChengxu MiaoJinghui Lu. (2024) Efficacy and safety of tyrosine kinase inhibitors for advanced metastatic thyroid cancer: A systematic review and network meta-analysis of randomized controlled trials. Medicine 103:15, pages e37655.
Crossref
Jiayi Yu, Zheran Liu, Yonglin Su, Xingchen Peng & Yuping Xie. (2024) Tyrosine kinase inhibitors for radioiodine refractory differentiated thyroid cancer: A systematic review and meta‐analysis. Clinical Endocrinology 100:4, pages 379-388.
Crossref
Sarvesh Loharkar & Sandip Basu. (2022) Hurthle Cell Thyroid Carcinoma with Liver and Paraaortic Abdominal Nodal Metastasis: Progression on Sorafenib Therapy after Initial Disease Stabilization. World Journal of Nuclear Medicine 22:01, pages 070-074.
Crossref
Judy K. QiangRaad AlwithenaniElizabeth Uleryk, Shereen EzzatLorraine L. LipscombeAnna M. Sawka. (2023) Risk of Adverse Cardiovascular Outcomes in Differentiated Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis. Thyroid 33:2, pages 192-202.
Crossref
Hao Zhao, Chun-Hao Liu, Yue Cao, Li-Yang Zhang, Ya Zhao, Yue-Wu Liu, Hong-Feng Liu, Yan-Song Lin & Xiao-Yi Li. (2022) Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis. Frontiers in Oncology 12.
Crossref
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo & Teresa Alonso-Gordoa. (2022) Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies. Cancer Treatment Reviews 105, pages 102372.
Crossref
Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Armando Patrizio, Sabrina Rosaria Paparo, Gianni Marone, Maria Rosaria Galdiero, Giovanni Guglielmi, Rudy Foddis, Alfonso Cristaudo & Alessandro Antonelli. (2022) Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin. Seminars in Cancer Biology 79, pages 203-216.
Crossref
Sabina Sheppard‐Olivares, Nora M. Bello, Elizabeth Wood, Anna Szivek, Barbara Biller, Samuel Hocker & Raelene M. Wouda. (2020) Toceranib phosphate in the treatment of canine thyroid carcinoma: 42 cases (2009‐2018). Veterinary and Comparative Oncology 18:4, pages 519-527.
Crossref
Claudio Maurizio Pacella, Enrico Di Stasio, Rinaldo Guglielmi, Alberto Baroli, Luca Pedrazzini, Irene Misischi, Agnese Persichetti & Enrico Papini. (2020) Role of laser ablation in multimodal treatment of radioiodine- refractory bone metastases of thyroid cancer: a retrospective study. Endocrine 70:2, pages 338-347.
Crossref
Rudolf Roka. (2020) Surgical treatment of locally advanced thyroid cancer. Innovative Surgical Sciences 5:1-2, pages 27-34.
Crossref
Dong Yun Lee & Yong-il Kim. (2020) Peptide Receptor Radionuclide Therapy in Patients With Differentiated Thyroid Cancer. Clinical Nuclear Medicine 45:8, pages 604-610.
Crossref
María San Román Gil, Javier Pozas, Javier Molina-Cerrillo, Joaquín Gómez, Héctor Pian, Miguel Pozas, Alfredo Carrato, Enrique Grande & Teresa Alonso-Gordoa. (2020) Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy. International Journal of Molecular Sciences 21:14, pages 4951.
Crossref
Emanuela Vaccher, Ornella Schioppa, Ferdinando Martellotta, Giulia Fornasier, Elisa Giacomin, Francesco Lo Re, Paolo Baldo, Giuseppe Corona & Carlo Gobitti. (2019) Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid Cancer. Recent Patents on Anti-Cancer Drug Discovery 14:3, pages 226-241.
Crossref
Yang Bai, Jing-Yan Li, Jie Li, Bo Zhang, Yong-Hong Liu, Bu-Yong Zhang & Jian Jing. (2018) Risk of venous and arterial thromboembolic events associated with tyrosine kinase inhibitors in advanced thyroid cancer: a meta-analysis and systematic review. Oncotarget 10:41, pages 4205-4212.
Crossref
Chiara Saglietti, Stefano La Rosa, Gerasimos P. Sykiotis, Igor Letovanec, Jean-Luc Bulliard, Simonetta Piana, Maxime Mermod, Tatiana Petrova, Silvia Uccella, Fausto Sessa & Massimo Bongiovanni. (2019) Expression of Prox1 in Medullary Thyroid Carcinoma Is Associated with Chromogranin A and Calcitonin Expression and with Ki67 Proliferative Index, but Not with Prognosis. Endocrine Pathology 30:2, pages 138-145.
Crossref
Pierpaolo Trimboli, Marco Castellana, Camilla Virili, Francesco Giorgino & Luca Giovanella. (2018) Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.